Results 71 to 80 of about 7,001,644 (259)

Gray matter atrophy rate as a marker of disease progression in AD. [PDF]

open access: yes, 2012
Global gray matter (GM) atrophy rates were quantified from magnetic resonance imaging (MRI) over 6- and 12-month intervals in 37 patients with Alzheimer's disease (AD) and 19 controls using: (1) nonlinear registration and integration of Jacobian values ...
Nick C. Fox   +11 more
core   +1 more source

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine   +21 more
wiley   +1 more source

Identification and evaluation of biomarkers for Huntington’s disease [PDF]

open access: yes, 2009
Huntington’s disease (HD) is a devastating, incurable inherited neurodegenerative disorder that commonly affects adults in mid-life. Despite encouraging results from in vitro and animal trials, disease-modifying therapeutic trials in HD are limited by ...
Wild, E.J.
core  

Impact of Initial Treatment Setting on Survival in Relapsed Pediatric and AYA Bone Sarcomas: A Secondary Analysis of a Prospective Clinical Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak   +9 more
wiley   +1 more source

Evidence for exponential progression in advanced Parkinson’s disease: retrospective analysis of a prospective cohort study

open access: yesFrontiers in Neurology
IntroductionWhile prospective cohort research in Parkinson’s disease (PD) suggests a linear increase in motor disability, there is some clinico-pathological evidence for exponential progression in the final disease stage.MethodsThirty-four patients with ...
Sophie Merve Yener   +10 more
doaj   +1 more source

Correlation of Salivary and Serum Calprotectin Levels in Patients with Periodontitis - Stage II and III, before and after Non Surgical Periodontal Therapy: A Clinicobiochemical Case Control Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Calprotectin (CPT), a major cytoplasmic protein in neutrophils, is released from myeloid cells during inflammation. It exerts pro-inflammatory effects on various cell types and plays a prominent role in tissue breakdown.
Subramani Varshini   +3 more
doaj   +1 more source

Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial

open access: yesRenal Failure, 2021
Background Immunoglobulin A nephropathy (IgAN) is the most common cause of glomerulonephritis worldwide, and the optimal approach to its treatment remains a significant challenge.
Zhaohui Ni   +13 more
doaj   +1 more source

Neurocognitive, School‐Based, and Quality of Life Outcomes for Youth With Sickle Cell Disease and Thalassemia: A Scoping Review

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT The medical burdens of sickle cell disease (SCD) and transfusion‐dependent β‐thalassemia (TDT) are chronic and cumulative, even in children. Yet the effects expand beyond medications and healthcare visits due to their impacts on school attendance, academic performance, and peer engagement.
Mary Ann Etling   +2 more
wiley   +1 more source

Cortisol, Amyloid- , and Reserve Predicts Alzheimer's disease progression for cognitively normal older adults [PDF]

open access: yes, 2019
Elevated cortisol as a measure of hypothalamic-pituitary-adrenal-axis hyperactivity has emerged as a predictor of clinical progression of Alzheimer’s disease (AD), in conjunction with amyloid-β (Aβ) abnormalities.
Su, Bowen   +15 more
core   +1 more source

Representation of Sickle Cell Disease Patients in Pediatric and Adult Care: What We Discovered Using Informatics for Integrating Biology and the Bedside (i2b2) Data

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Transitioning from pediatric to adult care is a high‐risk period for individuals with sickle cell disease (SCD). An initial observation at one academic medical center suggested a sex‐based disparity in clinic populations, prompting a national investigation.
Laurie J. Duckworth   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy